Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis-Reference-Cited by-同舟云学术

Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis

Published:2017-05-05 Issue:5 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Baker William L.¹,Buckley Leo F.²,Kelly Michael S.³,Bucheit John D.²,Parod Eric D.²,Brown Roy⁴,Carbone Salvatore⁵⁶,Abbate Antonio⁵,Dixon Dave L.²

Affiliation:

1. Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT

2. Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA

3. Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, CA

4. School of Nursing, Virginia Commonwealth University, Richmond, VA

5. VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA

6. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition

2. Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

3. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

4. U.S. Food and Drug Administration . FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm531517.htm. Accessed January 11 2017.

5. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of intelligent management mode based on Internet of Things on self-management ability and prognosis of elderly patients with hypertensive heart disease: An observational study;Medicine;2024-05-31

2. Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review;Consilium Medicum;2024-05-20

3. European guidelines for the treatment of arterial hypertension 2023: new trends;Meditsinskiy sovet = Medical Council;2024-05-09

4. Effect of Sodium-Glucose Cotransporter 2 Inhibitors on the 24-Hour Ambulatory Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension: An Updated Meta-Analysis;Endocrine Practice;2024-05

5. Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors;Hypertension Research;2024-04-10